BACKGROUND: There are limited reports on HIV-1 RNA load, CD4+ T-lymphocytes and antibody responses in relation to disease progression in HIV-1 infected untreated children in Africa. METHODS: To describe the relationships between these parameters, we conducted a longitudinal cohort study involving 51 perinatally HIV-1 infected children aged between 1 and 13 years. HIV status was determined by ELISA and confirmed by western blot and PCR. Antibodies were quantified by limiting dilution ELISA, plasma HIV-1 RNA load by RT-PCR and CD4+ T-lymphocytes by FACSCount. RESULTS: Asymptomatic and symptomatic disease had, respectively, a rise in median HIV-1 RNA load from 1,195 to 132,543 and from 42,962 to 1,109,281 copies/ml in children below 6 years. The increase in viral load was 10-fold higher for asymptomatic compared to other categories and 2-fold faster for children less than 6 years than those above. Similarly, symptomatic children below 6 years had initial median CD4+ T-lymphocyte counts of 647 (22%) cells/muL, declining to 378 (20%) while those above 6 years had initial values of below 335 (15%) but which increased to 428 (17%). Median viral load correlated significantly with median CD4+ T-lymphocyte percentage in children above 6 years (p=0.026) but not below. CONCLUSIONS: Viral load is lower in older than younger children and correlates significantly with percentage CD4+ T-lymphocytes. Survival by HIV-1 infected children requires a competent immune response early in infection to counter the rapidly replicating virus. Interventions aimed at boosting the naïve immune system may prolong survival in these children.
BACKGROUND: There are limited reports on HIV-1 RNA load, CD4+ T-lymphocytes and antibody responses in relation to disease progression in HIV-1 infected untreated children in Africa. METHODS: To describe the relationships between these parameters, we conducted a longitudinal cohort study involving 51 perinatally HIV-1 infectedchildren aged between 1 and 13 years. HIV status was determined by ELISA and confirmed by western blot and PCR. Antibodies were quantified by limiting dilution ELISA, plasma HIV-1 RNA load by RT-PCR and CD4+ T-lymphocytes by FACSCount. RESULTS: Asymptomatic and symptomatic disease had, respectively, a rise in median HIV-1 RNA load from 1,195 to 132,543 and from 42,962 to 1,109,281 copies/ml in children below 6 years. The increase in viral load was 10-fold higher for asymptomatic compared to other categories and 2-fold faster for children less than 6 years than those above. Similarly, symptomatic children below 6 years had initial median CD4+ T-lymphocyte counts of 647 (22%) cells/muL, declining to 378 (20%) while those above 6 years had initial values of below 335 (15%) but which increased to 428 (17%). Median viral load correlated significantly with median CD4+ T-lymphocyte percentage in children above 6 years (p=0.026) but not below. CONCLUSIONS: Viral load is lower in older than younger children and correlates significantly with percentage CD4+ T-lymphocytes. Survival by HIV-1 infectedchildren requires a competent immune response early in infection to counter the rapidly replicating virus. Interventions aimed at boosting the naïve immune system may prolong survival in these children.
Authors: W T Shearer; T C Quinn; P LaRussa; J F Lew; L Mofenson; S Almy; K Rich; E Handelsman; C Diaz; M Pagano; V Smeriglio; L A Kalish Journal: N Engl J Med Date: 1997-05-08 Impact factor: 91.245
Authors: T E Taha; N I Kumwenda; D R Hoover; R J Biggar; R L Broadhead; S Cassol; L van der Hoven; D Markakis; G N Liomba; J D Chiphangwi; P G Miotti Journal: AIDS Date: 2000-03-10 Impact factor: 4.177
Authors: M L Romiti; C Colognesi; C Cancrini; A Mas; M Berrino; F Salvatori; P Orlandi; M Jansson; E Palomba; A Plebani; J M Bertran; M Hernandez; M de Martino; A Amoroso; P A Tovo; P Rossi; T Espanol; G Scarlatti Journal: Mol Med Date: 2000-01 Impact factor: 6.354
Authors: A M Vandamme; K Fransen; L Debaisieux; D Marissens; S Sprecher; D Vaira; A T Vandenbroucke; C Verhofstede Journal: J Virol Methods Date: 1995-02 Impact factor: 2.014
Authors: Ruth S Mwatelah; Raphael M Lwembe; Saida Osman; Bernhards R Ogutu; Rashid Aman; Rose C Kitawi; Laura N Wangai; Florence A Oloo; Gilbert O Kokwaro; Washingtone Ochieng Journal: PLoS One Date: 2015-07-24 Impact factor: 3.240
Authors: Soledad Colombe; Paul L A M Corstjens; Claudia J de Dood; Donald Miyaye; Ruth G Magawa; Julius Mngara; Samuel E Kalluvya; Lisette van Lieshout; Govert J van Dam; Jennifer A Downs Journal: Front Immunol Date: 2018-09-06 Impact factor: 7.561